These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 620717)
21. Relative DNA damage induced in cultured human skin fibroblasts by exposure to the precarcinogen 2-acetylaminofluorene, the proximate carcinogen N-hydroxy-2-acetylaminofluorene, and the ultimate carcinogen N-acetoxy-2-acetylaminofluorene. Laishes BA; Stich HF Can J Biochem; 1973 Jul; 51(7):990-4. PubMed ID: 4725363 [No Abstract] [Full Text] [Related]
22. Effect of ovariectomy on the in vitro and in vivo activation of carcinogenic N-2-fluorenylhydroxamic acids by rat mammary gland and liver. Ritter CL; Bennett KK; Fullerton NF; Beland FA; Malejka-Giganti D Carcinogenesis; 1996 Nov; 17(11):2411-8. PubMed ID: 8968056 [TBL] [Abstract][Full Text] [Related]
23. On the metabolic activation of N-hydroxy-N-2-acetylamino-fluorene. II. Simultaneous formation of 2-nitrosofluorene and N-acetoxy-N-2-acetylaminofluorene from N-hydroxy-N-2-acetylaminofluorene via a free radical intermediate. Bartsch H; Traut M; Hecker E Biochim Biophys Acta; 1971 Jun; 237(3):556-66. PubMed ID: 4330270 [No Abstract] [Full Text] [Related]
24. Activation of certain N-arylacetamides and N-arylacetohydroxamic acids in relation to mammary gland tumorigenesis in the rat. Malejka-Giganti D Natl Cancer Inst Monogr; 1981 Dec; (58):69-77. PubMed ID: 6804871 [TBL] [Abstract][Full Text] [Related]
25. Enhancement of the mutagenicity of carcinogenic arylamines by ethinyl estradiol. Purdy RH; Marshall MV Carcinogenesis; 1984 Dec; 5(12):1709-15. PubMed ID: 6499122 [TBL] [Abstract][Full Text] [Related]
26. Radioactivity in rat mammary gland after the administration of 2-acetylaminofluorene-9- 14 C and its N-hydroxy metabolite. Janss DH; Irving CC J Natl Cancer Inst; 1972 Sep; 49(3):765-71. PubMed ID: 4647496 [No Abstract] [Full Text] [Related]
27. Free-radical events in chemical and biochemical reactions involving carcinogenic arylamines. Floyd RA Radiat Res; 1981 May; 86(2):243-63. PubMed ID: 6262857 [No Abstract] [Full Text] [Related]
28. Comparative toxicity of N-hydroxy-2-acetylaminofluorene in several strains of rats. Irving CC Cancer Res; 1975 Nov; 35(11 Pt 1):2959-61. PubMed ID: 1182689 [TBL] [Abstract][Full Text] [Related]
29. Debenzoylating and deacetylating activities of rat liver and mammary gland microsomes. Effect of ovariectomy. Ritter CL; Malejka-Giganti D Biochem Pharmacol; 1995 Oct; 50(8):1265-72. PubMed ID: 7488243 [TBL] [Abstract][Full Text] [Related]
30. Nucleic acid guanine: reaction with the carcinogen N-acetoxy-2-acetylaminofluorene. Miller EC; Juhl U; Miller JA Science; 1966 Sep; 153(3740):1125-7. PubMed ID: 5918575 [TBL] [Abstract][Full Text] [Related]
31. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes. Razzouk C; Batardy-Grégoire M; Roberfroid M Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306 [TBL] [Abstract][Full Text] [Related]
32. The genotoxicity of aromatic amines in primary hepatocytes isolated from C57BL/6 and DBA/2 mice. Møller ME; Glowinski IB; Thorgeirsson SS Carcinogenesis; 1984 Jun; 5(6):797-804. PubMed ID: 6722987 [TBL] [Abstract][Full Text] [Related]
33. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats. Jefferson FA; Xiao GH; Hein DW Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621 [TBL] [Abstract][Full Text] [Related]
34. Formation of electrophilic N-acetoxyarylamines in cytosoles from rat mammary gland and other tissues by transacetylation from the carcinogen N-hydroxy-4-acetylaminobiphenyl. Bartsch H; Dworkin C; Miller EC; Miller JA Biochim Biophys Acta; 1973 Mar; 304(1):42-55. PubMed ID: 4699998 [No Abstract] [Full Text] [Related]
35. Comparative electrophilicity, mutagenicity, DNA repair induction activity, and carcinogenicity of some N- and O-acyl derivatives of N-hydroxy-2-aminoflourene. Bartsch H; Malaveille C; Stich HF; Miller EC; Miller JA Cancer Res; 1977 May; 37(5):1461-7. PubMed ID: 322856 [TBL] [Abstract][Full Text] [Related]
36. Mechanism of in vitro mutagenic activation and covalent binding of N-hydroxy-2-acetylaminofluorene in isolated liver cell nuclei from rat and mouse. Sakai S; Reinhold CE; Wirth PJ; Thorgeirsson SS Cancer Res; 1978 Jul; 38(7):2058-67. PubMed ID: 26463 [No Abstract] [Full Text] [Related]
37. Lack of susceptibility of F344 rats to mammary tumor induction by topically applied fluorenylacetohydroxamic acids and their acetates. Malejka-Giganti D; Rydell RE J Natl Cancer Inst; 1978 Feb; 60(2):433-5. PubMed ID: 621757 [TBL] [Abstract][Full Text] [Related]
38. Enhancing and inhibiting effects of propyl gallate on carcinogen-induced mutagenesis. Rosin MP; Stich HF J Environ Pathol Toxicol; 1980 Aug; 4(1):159-67. PubMed ID: 7003048 [TBL] [Abstract][Full Text] [Related]
39. Lack of N-hydroxy-2-acetylaminofluorene sulfotransferase activity in the mammary gland and Zymbal's gland of the rat. Irving CC; Janss DH; Russell LT Cancer Res; 1971 Apr; 31(4):387-91. PubMed ID: 5553685 [No Abstract] [Full Text] [Related]
40. Initiation of hepatocarcinogenesis in infant male B6C3F1 mice by N-hydroxy-2-aminofluorene or N-hydroxy-2-acetylaminofluorene depends primarily on metabolism to N-sulfooxy-2-aminofluorene and formation of DNA-(deoxyguanosin-8-yl)-2-aminofluorene adducts. Lai CC; Miller EC; Miller JA; Liem A Carcinogenesis; 1987 Mar; 8(3):471-8. PubMed ID: 3815742 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]